867353-55-7Relevant academic research and scientific papers
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 64-65, (2008/06/13)
The present invention is directed to compounds which contain substituted 5-deazapteridine moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 69-70, (2010/02/14)
The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
